Olson, Caroline G.
Francis, Fadi F.
Yan, Irene K.
Nakhleh, Raouf
Tamim, Hani
Camilleri, Michael
Kurdi, Ahmed
Farraye, Francis A.
Hashash, Jana G.
Article History
Received: 21 August 2025
Accepted: 7 December 2025
First Online: 21 December 2025
Declarations
:
: FAF: Consulting Fee: Astellas, Avalo Therapeutics, Bausch, BMS, Braintree Labs, Fresenius Kabi, GI Reviewers, GSK, IBD Educational Group, Iterative Health, Janssen, Pharmacosmos, Pfizer, Sandoz Immunology, Viatris. DSMB: Eli Lilly. The rest of the authors have no conflicts to declare.
: None.